Into AGQ @ 30.86. Silver trading just under $15.00 today (now about 14.96) after a recent run up to the high 15's, near $16.00. Have traded AGQ before. Tracks the SLV (1 X silver ETF) pretty well with very little price decay over extended periods of time.
Would be nice to see some analyst updates or comments in light of the China deal. Maybe a bump up in EPS estimates. One of the best times to buy a biotech type stock is when the company is just moving to profitability from losses. That's right where RMTI is now.
Avanir (AVNR, now bought out) literally sat on the EU approval of Nuedexta for 2 years, didn't seriously pursue a partner, and eventually got acquired by a major Japanese pharma. The name escapes me right now.
The similarities between these 2 companies is stunning. AVNR had the same problem with 'N' as KERX is having with 'A.' High expectations on the roll out that disappointed for the first several quarters. AVNR also had to fight through a patent battle that they eventually won. That is what ultimately opened the door to them being acquired. AVNR was one of the best biotechs I ever held.
I know there's others here that were LT AVNR holders as I was...........do you also see the parallels?
Shorts trying to cover as cheaply as possible. Longs trying to panic them. Last 15 minutes up until 4:00 pm eastern could be wild.
Kel.............an entertained holder
Added some @ 4.98. Today's news plus the EU approval still waiting for a partnership. A core of good news just waiting for buyers to recognize the improving situation here. Upgrades may be coming in the near future as well.
Much covering since the drop below 30 cents. Got in Friday @ 28 cents. Been here before, but never at prices this low. I think the company did a lousy job selling such a small amount of shares that drove the price down over 30%.
But, it did create an opportunity for buyers like me below 30 cents. Has built a nice base over the lst 30 days.
Perhaps an equity (additional issued shares) swap for some or all of their debt. Basically, they're saying they've almost run out of money and that they're still operating because the vendors and creditors haven't forced them to file BK yet. At least that's what I read "between the lines." Things are desperate.
In @ 7.75. This secondary offering is like a gift on a silver platter. The company will now be in much better financial shape with another $1 billion+ in the coffers and we get the opportunity to scoop up shares near the lows.